PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,585,198 | -10.6% | 1,310,048 | +23.5% | 0.21% | -0.5% |
| Q2 2023 | $15,187,864 | +284.1% | 1,060,605 | +91.5% | 0.21% | +215.2% |
| Q1 2023 | $3,954,339 | -36.1% | 553,829 | +0.4% | 0.07% | -42.6% |
| Q4 2022 | $6,191,499 | +1.2% | 551,827 | -0.1% | 0.12% | +7.5% |
| Q3 2022 | $6,121,000 | +30.4% | 552,442 | -0.7% | 0.11% | +27.4% |
| Q2 2022 | $4,694,000 | -38.0% | 556,105 | -0.0% | 0.08% | +20.0% |
| Q1 2022 | $7,571,000 | -29.5% | 556,293 | +1.9% | 0.07% | +14.8% |
| Q4 2021 | $10,741,000 | -39.2% | 546,055 | -0.8% | 0.06% | -33.7% |
| Q3 2021 | $17,663,000 | -4.5% | 550,240 | +0.7% | 0.09% | +1.1% |
| Q2 2021 | $18,500,000 | -39.8% | 546,522 | -33.2% | 0.09% | -45.2% |
| Q1 2021 | $30,739,000 | – | 818,385 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |